Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5197-5204

  Zarling, Angela L ^a   Johnson, Julia G ^a   Hoffman, Robert W ^a   Lee, David R ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHROMIUM 51; MITOMYCIN C;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ISOLATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL SEPARATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HLA ANTIGENS; HUMANS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MACROPHAGES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033136722     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Wentworth, P. A., E. Celis, C. Crimi, S. Stitely, L. Hale, V. Tsai, H. M. Serra, M.-F. del Guercio, B. Livingston, D. Alazard, J. Fikes, R. T. Kubo, H. M. Grey, R. W. Chesnut, F. V. Chisari, and A. Sette. 1995. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol. 32:603.
2. Gagliardi, M. C., G. De Petrillo, S. Salemi, L. Boffa, M. G. Longobardi, P. Dellabona, G. Casorati, N. Tanigaki, R. Harris, A. Lanzavecchia, and V. Barnaba. 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7:1741.
3. + CTLs from naive precursors. J. Immunol. 153:996.
4. Tjandrawan, T., D. M. Martin, M. J. Maeurer, C. Castelli, M. T. Lotze, and W. J. Storkus. 1998. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro. J. Immunother. 21: 149.
5. Tsai, V., S. Southwood, J. Sidney, K. Sakaguchi, Y. Kawakami, E. Appella, A. Sette, and E. Celis. 1997. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol. 158:1796.
6. Tsai, V., I. Kawashima, E. Keogh, K. Daly, A. Sette, and E. Celis. 1998. In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells. Crit. Rev. Immunol. 18:65.
7. + helper T cells. J. Exp. Med. 171:1315.
8. + T cells of Tc1 and Tc2 phenotype. Blood 90:2089.
9. + hematopoietic progenitors from human and blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF-α. J. Exp. Med. 184:695.
10. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196:121.
11. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kämpgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137.
12. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
13. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
14. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 86:9514.
15. Harrer, T., E. Harrer, S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johnson, T. Elbeik, M. B. Feinberg, S. P. Buchbinder, and B. D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol. 156:2616.
16. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Köppe, W. Rosenberg, D. Boyd, A. Edwards, P. Glangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369:403.
17. Meier, U. C., P. Klenerman, P. Griffin, W. James, B. Köppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360.
18. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2-binding site. J. Exp. Med. 168: 2045.
19. Sutton, J., S. Rowland-Jones, W. Rosenberg, D. Dixon, F. Gotch, M. Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith, A. Willis, and A. J. McMichael. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447.
20. DiBrino, M., K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1994. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J. Biol. Chem. 269:32426.
21. Severson, C. D., D. L. Burg, D. E. Lafrenz, and T. L. Feldbush. 1987. An alternative method of panning for rat B lymphocytes. Immunol. Lett. 15:291.
22. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821.
23. + peripheral blood monocytes. J. Immunol. 157:3850.
24. d class I MHC molecule. Nature 344:439.
25. d ligands lacking the consensus P2 anchor. J. Immunol. 156:4266.
26. Zarling, A. L., and D. R. Lee. 1998. Conversion of a human immunodeficiency virus cytotoxic T lymphocyte epitope into a high affinity HLA-Cw3 ligand. Hum. Immunol. 59:472.
27. Toujas, L., J. G. Delcros, E. Diez, N. Gervois, G. Semana, G. Corradin, and F. Jotereau. 1997. Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunology 91:635.
28. Barouch, D., T. Friede, S. Stevanovic, L. Tussey, K. Smith, S. Rowland-Jones, V. Braud, A. McMichael, and H. G. Rammensee. 1995. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182:1847.
29. + T-helper and a T-killer cell. Nature 393: 474.
30. Bennett, S. R. M., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
31. Schoenberger, S. P., R. E. M. Toes, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
32. Hilkens, C. M. U., P. Kalinski, M. de Boer, and M. L. Kapsenberg. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90:1920.
33. Creery, W. D., F. Diaz-Mitoma, L. Filion, and A. Kumar. 1996. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur. J. Immunol. 26:1273.
34. + T-cell immune responses induced by dendritic cells. Immunology 85:467.
35. Fleischer, J., E. Soeth, N. Reiling, E. Grage-Griebenow, H. D. Flad, and M. Ernst. 1996. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood. Immunology 89:592.
36. Palmer, E. M., and G. A. van Seventer. 1997. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. J. Immunol. 158:2654.
37. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
38. Chambers, C. A., and J. P. Allison. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396.
39. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
40. Kim, Y. J., S. H. Kim, P. Mantel, and B. S. Kwon. 1998. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur. J. Immunol. 28:881.
41. Zhou, Z., S. Kim, J. Hurtado, Z. H. Lee, K. K. Kim, K. E. Pollok, and B. S. Kwon. 1995. Characterization of human homologue of 4-1BB and its ligand. Immunol. Lett. 45:67.
42. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
43. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of 0X40 ligand on human dendritic cells. J. Immunol. 159:3838.
44. + T cells. J. Immunol. 158:637.
45. Lotze, M. T., M. Shurin, I. Davis, A. Amoscato, and W. J. Storkus. 1997. Dendritic cell based therapy of cancer. Adv. Exp. Med. Biol. 417:551.
46. Hsu, F. J., C. Benike, F. Fagnoni, T. M. Liles, D. Czerwinski, B. Taidi, E. G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52.
47. Schuler, G., and R. M. Steinman. 1997. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186:1183.
48. Tuting, T., A. B. Deleo, M. T. Lotze, and W. J. Storkus. 1997. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo. Eur. J. Immunol. 27:2702.
49. Brossart, P., A. W. Goldrath, E. A. Butz, S. Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270.
50. Hermans, I. F., A. Daish, P. Moroni-Rawson, and F. Ronchese. 1997. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge. Cancer Immunol. Immunother. 44:341.
51. Ludewig, B., S. Ehl, U. Karrer, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1998. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72:3812.
52. Manickan, E., S. Kanangat, R. J. Rouse, Z. Yu, and B. T. Rouse. 1997. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:125.
53. Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533.